Macrophages: a Trojan horse in COVID-19?
作者信息
Park Matthew D
机构信息
Sinai Immunology Review Project, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
出版信息
Nat Rev Immunol. 2020 Jun;20(6):351. doi: 10.1038/s41577-020-0317-2.
Abstract
摘要
相似文献
1
Macrophages: a Trojan horse in COVID-19?巨噬细胞：新冠病毒肺炎中的特洛伊木马？
Nat Rev Immunol. 2020 Jun;20(6):351. doi: 10.1038/s41577-020-0317-2.
2
The solution to the seven mysteries of AIDS: the 'Trojan horse'.艾滋病七大谜团的解决方案：“特洛伊木马”。
Med Hypotheses. 1995 Jan;44(1):1-9. doi: 10.1016/0306-9877(95)90293-7.
3
Social responsibility during the COVID-19 pandemic: Tobacco industry's trojan horse in Europe.新冠疫情期间的社会责任：欧洲烟草业的特洛伊木马。
Tob Prev Cessat. 2020 Jun 15;6:37. doi: 10.18332/tpc/123244. eCollection 2020.
4
Endowing a Light-Inert Aqueous Surfactant Two-Phase System with Photoresponsiveness by Introducing a Trojan Horse.通过引入特洛伊木马赋予光惰性水性表面活性剂两相体系光响应性。
ACS Appl Mater Interfaces. 2019 Apr 24;11(16):15103-15110. doi: 10.1021/acsami.8b20817. Epub 2019 Apr 15.
5
Trojan horse anaesthesia: A novel method of anaesthesia for pars plana vitrectomy.特洛伊木马式麻醉：一种用于玻璃体切割术的新型麻醉方法。
Oman J Ophthalmol. 2018 May-Aug;11(2):119-123. doi: 10.4103/ojo.OJO_87_2017.
6
Is previous influenza-like illness a potential Trojan horse for COVID-19?既往流感样疾病会成为新冠病毒的潜在“特洛伊木马”吗？
Crit Care. 2020 Aug 14;24(1):503. doi: 10.1186/s13054-020-03226-5.
7
SARS-CoV-2 and Trojan horse phenomenon-caveat in vaccine quest?新型冠状病毒与特洛伊木马现象——疫苗研发中的警示？
Scand J Immunol. 2020 Dec;92(6):e12969. doi: 10.1111/sji.12969. Epub 2020 Oct 20.
8
Taming the Wildness of "Trojan-Horse" Peptides by Charge-Guided Masking and Protease-Triggered Demasking for the Controlled Delivery of Antitumor Agents.通过电荷引导掩蔽和蛋白酶触发解蔽来驯服“特洛伊木马”肽的野性，用于抗肿瘤药物的控制释放。
ACS Appl Mater Interfaces. 2017 Mar 29;9(12):10519-10529. doi: 10.1021/acsami.7b01056. Epub 2017 Mar 14.
9
Trojan Horse Transit Contributes to Blood-Brain Barrier Crossing of a Eukaryotic Pathogen.特洛伊木马转运促进真核病原体穿越血脑屏障。
mBio. 2017 Jan 31;8(1):e02183-16. doi: 10.1128/mBio.02183-16.
10
Delivery of Biologics Across the Blood-Brain Barrier with Molecular Trojan Horse Technology.利用分子木马技术将生物制剂递送到血脑屏障。
BioDrugs. 2017 Dec;31(6):503-519. doi: 10.1007/s40259-017-0248-z.
引用本文的文献
1
Divergent biological pathways distinguish community-acquired pneumonia from COVID-19 despite similar plasma cytokine profiles.尽管血浆细胞因子谱相似，但不同的生物学途径可区分社区获得性肺炎和新冠肺炎。
Respir Res. 2025 Aug 31;26(1):264. doi: 10.1186/s12931-025-03331-5.
2
Development and Validation of the CARRA-VID Prognostic Score: C Reactive Protein to Albumin Ratio, Red Blood Cell Distribution Width and Age-Based Score for Prognostication of Hospitalized COVID-19 Patients.CARRA-VID预后评分的开发与验证：基于C反应蛋白与白蛋白比值、红细胞分布宽度和年龄的住院COVID-19患者预后评分
Viruses. 2025 Apr 27;17(5):629. doi: 10.3390/v17050629.
3
Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染的免疫和炎症后果及其在肾脏疾病中的意义。
Front Immunol. 2025 Feb 12;15:1376654. doi: 10.3389/fimmu.2024.1376654. eCollection 2024.
4
Enterococcus and Eggerthella species are enriched in the gut microbiomes of COVID-19 cases in Uganda.在乌干达，粪肠球菌和埃格特菌属在新冠肺炎病例的肠道微生物群中富集。
Gut Pathog. 2025 Feb 4;17(1):9. doi: 10.1186/s13099-025-00678-4.
5
Transcriptomic profiles of monocyte-derived macrophages exposed to SARS-CoV-2 VOCs reveal immune-evasion escape driven by delta.暴露于新冠病毒变异株的单核细胞衍生巨噬细胞的转录组图谱揭示了由德尔塔驱动的免疫逃逸。
J Transl Med. 2025 Feb 4;23(1):151. doi: 10.1186/s12967-025-06158-2.
6
New-onset refractory status epilepticus after SARS-CoV-2 infection: a review of literature.新型冠状病毒2感染后新发难治性癫痫持续状态：文献综述
Croat Med J. 2024 Dec 30;65(6):510-517. doi: 10.3325/cmj.2024.65.510.
7
The Impact of SARS-CoV-2 on the Human Immune System and Microbiome.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）对人类免疫系统和微生物群的影响。
Infect Microbes Dis. 2020 Dec 23;3(1):14-21. doi: 10.1097/IM9.0000000000000045. eCollection 2021 Mar.
8
COVID-19 and the brain: understanding the pathogenesis and consequences of neurological damage.新型冠状病毒肺炎与脑：认识神经系统损伤的发病机制和后果。
Mol Biol Rep. 2024 Feb 22;51(1):318. doi: 10.1007/s11033-024-09279-x.
9
A Review on Role of Inflammation in Coronavirus Disease.炎症在冠状病毒病中的作用综述
Endocr Metab Immune Disord Drug Targets. 2024;24(13):1488-1505. doi: 10.2174/0118715303265274231204075802.
10
Leveraging immunoliposomes as nanocarriers against SARS-CoV-2 and its emerging variants.利用免疫脂质体作为针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）及其新出现变体的纳米载体。
Asian J Pharm Sci. 2023 Nov;18(6):100855. doi: 10.1016/j.ajps.2023.100855. Epub 2023 Oct 20.
Zotero 插件